StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.71+0.04 (+2.36%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

Genprex net income

Net income is the profit left for shareholders after every expense, interest and tax.

Genprex's net income for the twelve months ending Jun 30, 2026 was -$16.50M. For fiscal 2025 it was -$16.23M. The highest annual figure on record is -$3.31M in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$16.23M–
FY2024Dec 31, 2024-$21.11M–
FY2023Dec 31, 2023-$30.86M–
FY2022Dec 31, 2022-$23.74M–
FY2021Dec 31, 2021-$20.66M–
FY2020Dec 31, 2020-$17.94M–
FY2019Dec 31, 2019-$10.65M–
FY2018Dec 31, 2018-$12.37M–
FY2017Dec 31, 2017-$3.31M–
FY2016Dec 31, 2016-$4.13M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.45M–
Q1 FY2026Mar 31, 2026-$4.46M–
Q4 FY2025Dec 31, 2025-$3.79M–
Q3 FY2025Sep 30, 2025-$3.80M–
Q2 FY2025Jun 30, 2025-$4.67M–
Q1 FY2025Mar 31, 2025-$3.96M–
Q4 FY2024Dec 31, 2024-$4.33M–
Q3 FY2024Sep 30, 2024-$4.32M–
Q2 FY2024Jun 30, 2024-$6.50M–
Q1 FY2024Mar 31, 2024-$5.97M–
Q4 FY2023Dec 31, 2023-$5.93M–
Q3 FY2023Sep 30, 2023-$7.75M–
Q2 FY2023Jun 30, 2023-$7.98M–
Q1 FY2023Mar 31, 2023-$9.20M–
Q4 FY2022Dec 31, 2022-$6.52M–
Q3 FY2022Sep 30, 2022-$6.14M–
Q2 FY2022Jun 30, 2022-$5.76M–
Q1 FY2022Mar 31, 2022-$5.31M–
Q4 FY2021Dec 31, 2021-$6.75M–
Q3 FY2021Sep 30, 2021-$3.44M–
Q2 FY2021Jun 30, 2021-$3.99M–
Q1 FY2021Mar 31, 2021-$5.31M–
Q4 FY2020Dec 31, 2020-$5.23M–
Q3 FY2020Sep 30, 2020-$2.77M–
Q2 FY2020Jun 30, 2020-$4.37M–
Q1 FY2020Mar 31, 2020-$5.57M–
Q4 FY2019Dec 31, 2019-$2.42M–
Q3 FY2019Sep 30, 2019-$2.38M–
Q2 FY2019Jun 30, 2019-$3.70M–
Q1 FY2019Mar 31, 2019-$2.16M–
Q4 FY2018Dec 31, 2018-$3.43M–
Q3 FY2018Sep 30, 2018-$2.19M–
Q2 FY2018Jun 30, 2018-$6.06M–
Q1 FY2018Mar 31, 2018-$694.00K–
Q4 FY2017Dec 31, 2017-$666.58K–
Q3 FY2017Sep 30, 2017-$715.10K–
Q2 FY2017Jun 30, 2017-$1.18M–
Q1 FY2017Mar 31, 2017-$751.30K–
Q4 FY2016Dec 31, 2016-$999.07K–
Q3 FY2016Sep 30, 2016-$719.86K–

More Genprex figures

See a number that looks wrong?